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Abstract
Background: Microarray studies of the same phenomenon in different labs often appear at
variance because the published lists of regulated transcripts have disproportionately small
intersections. We demonstrate that comparing studies by intersecting lists in this manner is
methodologically flawed by reanalyzing three studies of the molecular signature of "stemness" in
human embryonic stem cells. There are only 7 genes common to all three published lists, suggesting
disagreement.
Results:  Carefully reanalyzing all three together from the raw data we detect 111 genes
upregulated and 95 downregulated in all three studies. The upregulated list was subject to rtRTPCR
analysis and 75% of the genes were confirmed.
Conclusion: Our findings show that the three studies have a substantial core of common genes,
which is missed if only the published lists are examined. Combined analysis of multiple experiments
can be a powerful way to distil coherent conclusions.
Background
A grave concern in the use of microarray technology is the
apparently little agreement between different studies of
the same phenomenon carried out in different laborato-
ries, or even in the same lab using different platforms. Par-
ticularly evident is the "small intersection" problem:
when several competing studies each conclude with a
large list of "statistically significant" genes – yet the inter-
section between the published lists is ridiculously small.
This problem undermines confidence in the technol-
ogy[1] or, potentially worse, may misdirect the researchers
into suspecting strange biological processes. When the
subject matter is itself under contention then controver-
sies may erupt [2-6]. The repeatability of microarray
experiments across labs and platforms has become a hot
current topic of discussion in the microarray community,
with some studies suggesting that reproducibility across
platforms is poor [7-9] while other studies indicate that
biological and laboratory variability are larger sources of
discrepancy than platforms or technologies [10-13], and
with other studies pointing out annotations can be a
source of problems[14].
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We set out to study whether indeed different studies can-
not be reconciled or whether the small intersection prob-
lem is artifactual, for one concrete problem of great
scientific and extra-scientific importance: human embry-
onic stem cells (HESC). Isolation of HESC lines has gen-
erated the exciting possibility of both access to the basic
science of human development as well as the possibility
of new hope for cell-based therapy in the clinic[15]. The
realization of these clinical goals depends on an under-
standing of the molecular basis of signaling pathways that
maintain ESCs in an undifferentiated, pluripotent state,
and microarray studies of HESCs should provide a sound
basis for discovery and exploration of these pathways.
We shall consider 3 microarray studies of HESCs: Battach-
arya[16], Sperger[17] and Sato[18]. These studies had
considerable differences, both in platforms (See Table 1)
as well as biological. The Bhattacharya and Sperger studies
have none or few replicates, hybridizing instead different
cell lines to each chip, and contrast to different control
samples of pools of differentiated tissues. The Sato study
analyzed triplicates of a single cell line compared against
"nonlineage induced differentiation" of that same cell
line. Maintenance conditions also varied; see Methods for
more details.
Each study concluded with a list of genes which are up-
regulated in stem cells. These lists are important because
they should show a good view of all pathways in the cell
for which there might be important stem-cell-specific
functions, not just developmental signaling pathways, but
also potential stem-cell-specific "housekeeping" genes.
Most studies have a tendency to focus on developmentally
important pathways, such as those that are sufficient for
self-renewal; a genome-wide search giving us an unbiased
list of up-regulated transcripts is supposed to give us a
wider view into the state of stemness.
But the three lists of significantly up-regulated genes, as
published, are quite different from each other. Their inter-
section is shown in Figure 1: seven genes appear in all
three studies out of 2226 total genes in the union of the
three published lists. This is particularly troublesome
since all three studies appear to be technically reliable and
each study has good reproducibility between replicates
(see Methods: "Within platform variations"). The inter-
section highlights mainly metabolic or housekeeping
genes; significantly, few of these have been implicated in
any of the nine major developmentally important signal-
ing pathways.
The small intersection is a big problem: it is generally
taken to mean that the results are not reproducible from
laboratory to laboratory and should not be believed. We
shall show that this is not the case, that comparing the
lists in this manner is methodologically flawed and that
the experiments do have a large core of common genes.
No experimental scientist would be surprised when
results change upon a change of protocol; the analysis of
microarray data, from image analysis to the statistical pro-
cedure, has as many parameters as a biochemical proto-
col, and hence there's little surprise that lists obtained by
widely different "statistical protocols" are incompatible,
so we shall now set about the task of defining and apply-
ing a single such statistical protocol to these studies.
Results
In an experiment addressing differential gene expression,
a common criterion to choose a p-value is the largest tol-
erable amount of false positives; then the power of the test
to detect the true positives will depend on the difference
between condition and control, the replication variability,
the number of replicates and other parameters. In order to
be at the intersection between three lists, a gene must have
passed such a test three independent times, which it does
with a probability equal to the product of the probabili-
ties of each test. Therefore the intersection's p-value is the
cube of the lists' p-value. This strongly throws off the bal-
ance between sensitivity and specificity, with the result
that the intersection becomes insensitive and carries few
genes (See section D1 of Additional file 1 –
Supplementary Discussion and Methods.). The lists which
are good for publishing are inadequate for intersecting; in
Table 1: Summary of platforms
Bhattacharya Sperger Sato
Platform cDNA - cDNA – 12 × 4 Affy – HGU133a
Chip design 8 × 4, 23 × 23 12 × 4, 30 × 30 650 × 650
Scanner GenePix 4000B GenePix 4000 GeneArray
Image Analysis Software GenePix 3.0 Gene Pix 3.0 MAS Suite
Spot/probes (per chip) 16 928 43200 / 43008 22 283
UniGene 12041 25 400 12 441
Empty spots per chip 238 531 -BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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order to generate the best intersection the lists have to be
recomputed.
We procured the raw data from all three studies, and re-
analyzed it using consistent criteria for spot quality, nor-
malization and summarization, in order to obtain the
expression measures for the three studies. Since all three
platforms are different (see Methods: "description of stud-
ies") they have many genes which are not in common and
so could not possibly be at the intersection. We carefully
screened UniGene numbers to obtain the set of 7373
genes common to all 3 microarray platforms, which is the
"universe" of our study. Most of these genes show varia-
tions between stem lineage and differentiated control
which are no larger than replication errors.
Eliminating them increases the power of our analysis and
thus we kept for further study only those 2463 genes in
this set that displayed variations across the samples, since
only these could be differentially expressed genes. It
should be emphasized that our universe does not include
all of the genes possibly involved in stemness. For exam-
ple some genes, like TDGF1 (Hs385870), Nanog
(Hs329296), DNMT3B (Hs252613), FOXD3
(Hs424212), OTX2 (Hs288655), MyosinX (Hs481720),
HEY2 (Hs144287), FGF4 (Hs1755), Rex1 (Hs335787)
and Nodal (Hs370414), most of which were highlighted
as up-regulated in HESCs in various studies, were not
included in our "universe" because they are missing from
at least one of the three different chip designs.
We then analyzed the genes by Integrated Correlation
Analysis[19] (see Methods), which was introduced to val-
idate the agreement among studies and to select genes that
exhibit a coherent behavior across different studies. The
idea is that while studying the same system, co-regulated
genes should exhibit correlated expression profiles, and
these correlations should be maintained across studies.
This quality of moving together with other genes we call
"coherence". Conversely, when extraneous factors affect a
small set of genes in a particular study, the correlations
between those genes and the rest shall not be maintained
across studies.
Figure 2 illustrates how "coherence" of genes between two
studies is quantified. For a pair of genes, the correlations
between their expression profiles are calculated within
each study and the correlation in one study is plotted
against the other; points near the identity line represent
pairs of genes which maintain their correlation values
across studies. The coherence score of a gene g is the cor-
relation coefficient of the points corresponding to all pairs
containing g. Using all gene pairs we obtain the integrated
correlation score, an overall measurement of agreement
between the two studies. We have changed the nomencla-
ture from [19], where coherence is called "consistency",
because we want to reserve the notion of consistency to
mean moving in the same direction from condition to
control in all studies (i.e., up-regulated in all studies).
Notice that no information about the condition and con-
trol is introduced in the definition of coherence; if the
genes are both up-regulated in study 1 and both down-
regulated in study 2 they are coherent because they behave
Common published genes Figure 1
Common published genes. Intersection (per UniGene) between the published lists of up-regulated genes for each study.BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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the same way with respect to each other within each study,
even though they are both inconsistent. (See Methods:
Coherence and Consistency)
Previous use of this analysis applied to classification of
cancer [19] yielded unimodal histograms of the gene-
coherence scores (there called "gene-reproducibility
score"); in our study, though, we obtain a strongly bimo-
dal histogram, shown in Figure 3, indicating that there is
a number of genes in strong agreement among the three
studies and a number of genes in strong disagreement.
(Further details, including bivariate density plots, can be
found in Additional file 1, section D4). There are a
number of potential reasons why genes could be strongly
incoherent as shown in these histograms discussed later.
Eliminating incoherent genes improves enormously the
general agreement between the studies. The improvement
in the integrated correlation score and the correlation
between log2-fold changes (M-values) is illustrated in Fig-
ure 3b. We decided to keep for further analysis the 739
genes in the top 30% of the gene-coherence score distribu-
tion. (Little variation of our final results was observed for
percentiles 40% and 50% since they only include positive
coherence scores; we present the stricter criterion). Not so
obviously, the correlation between the M-values between
studies also markedly improved from 0.35 to 0.76, 0.68,
and 0.66 respectively. (More detailed results about Inte-
grated Correlations results can be found in Additional file
1, section D4)
Once we restrict ourselves to this set of coherent genes, we
study those genes that are up- or down- regulated in stem
cells vs. their differentiated controls in each one of the
studies. We emphasize that exactly the same statistical
tests and criteria were applied to all three studies, with a
strict cutoff value selection based both on a p-value and a
positive lods [20]. We used the moderated t-statistics as
proposed by [21] and the FDR (BH) procedure was used
to adjust the p-values for multiple hypothesis [22]. This is
important because the set of coherent genes is enriched in
genes that are not statistically independent. The BH proce-
dure [23] controls FDR under certain general assumptions
(positive regression dependence) and simulations shows
its adequacy to control FDR in more general dependence
structures [24], while the BY procedure [25] is assump-
tion-free but is more conservative that BH. However, in
our case both procedures led to practically the same
results, because the proportion of differentially expressed
genes is higher in the coherent set; we report the results
Coherence Scores Figure 2
Coherence Scores. Given the expression profile for four genes A, B, C, and D in two studies 1 and 2 shown in panel (a), we 
can calculate the correlation of the expression profiles for every pair of genes in each of the two studies. In panel (b) those 
pairwise correlations are plotted for study 1 against study 2. For example, pair AB is positively correlated in both studies and 
pair BD is negatively correlated in study 1 and positively in study 2. Correlations for pairs AB, AC, AD lie approximately on a 
line of positive slope, so gene A is called "coherent". The coherence score of A is the correlation coefficient of those points, 
which is positive. Gene D has a negative correlation coefficient and so is incoherent. Study 3 in panel (c) is study 2 where con-
dition and control have been swapped; all genes are perfectly coherent for studies 2 and 3, yet each gene which is up-regulated 
in study 2 is down-regulated in study 3.BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
Page 5 of 11
(page number not for citation purposes)
from the BH. P-value cutoff was set in 0.01, which implies
than the probability of error is 10-4 in the pairwise com-
parison and 10-6 when the three studies are considered.
The intersection between the lists is now quite larger and
statistically significant, as shown in Figure 4; the 111 up-
regulated and 95 down-regulated genes common to all
three studies (vs. 3 expected by chance intersections) are
listed in Additional file 2 and Additional file 3 online.
Notice that the 111 up-regulated genes in this list are not
necessarily the "most" up-regulated for any individual
study; yet they are significantly up-regulated for each
study.
We performed real-time RT-PCR analysis of the up-regu-
lated genes to validate our findings. In an initial experi-
ment, H1 HESCs were differentiated for 30 days with RNA
samples taken before and after differentiation. We suc-
ceeded in analyzing 106 genes out of the 111 intersecting
HESC enriched genes in triplicate for expression level
changes upon differentiation by real-time RT-PCR (See
Additional file 4 for primers used in real-time RT-PCR).
After screening for significant differences (within this
experiment) between the mean normalized Ct values
(Student's t-test, p > 0.05, n = 3), between differentiated
and undifferentiated samples, 87 genes (82%) had differ-
ences in expression. Of these, 77 (89%) were enriched in
undifferentiated HESCs and 10 (11%) were enriched in
differentiated HESCs. Overall, 88 of the 106 tested genes
(83%) were enriched in undifferentiated HESCs (p = 1.5
× 10-12 in the exact binomial test); 77 of them also signif-
icant by RT-PCR, for a 73% of success probability (p = 1.7
× 10-6). 9% were enriched in the differentiated sample and
18% were either not regulated or not significant in this
Coherence Scores Distribution Figure 3
Coherence Scores Distribution. The histograms of the coherence scores are bimodal. (a) Pairwise comparisons, and aver-
aged score over all three comparisons. This implies that in these studies the genes can be divided into two distinct categories, 
coherent and incoherent. When "erratic" genes are discarded, there is a marked improvement in the agreement between stud-
ies. b) Integrated Correlation and Correlation of M-values calculated using the genes in the top percentiles of Coherence 
Score, red: Bhattacharya-Sperger, blue: Bhattacharya-Sato, black: Sperger-SatoBMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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experiment. (See Additional file 5 for the raw data of real-
time RT-PCR results)
A comparison between the fold changes found through
real-time RT-PCR and those obtained in the three studies
is shown in Figure 5. Our real-time RT-PCR test was car-
ried out under identical cell line, culture and differentia-
tion conditions to the Sato study, so we present
comparisons against the mean log-fold-change of the
three studies and against Sato's study separately, which
has for evident reasons better fit. Positive slopes and cor-
relation coefficients are obtained in all comparisons; cor-
relations are higher when fitting only to genes with real-
time RT-PCR log2 fold-changes bigger than 0.5, becoming
0.6 when comparing only to Sato's study. These slopes
and correlation coefficients are in line with general results
in the literature comparing different microarray platforms
and real-time RT-PCR results for the same RNA sample.
Discussion
How can we reconcile the agreement in Figure 4 with the
disagreement in Figure 1? Figure 4 displays an incorrect
comparison, since intersecting lists in this manner is
flawed methodology. The three lists were created from dif-
ferent sets of genes using different statistical criteria for
ranking the transcripts; they really are apples and oranges
and should not be compared so lightly. To mention but
three exemplars of problems with such comparison:
- there are more than 40000 genes in Sperger's study, yet
only 7373 are common to all three arrays, so about 4/5 of
the genes studied by Sperger were not studied in some
other study; in fact, more than 650 genes in the published
list could not possibly have been at the intersection.
- the size of the intersection cannot be larger than the
smallest list and is thus controlled by it; in this case the
Bhattacharya study had far more stringent criteria and
reported the fewest genes; notice that about 2/3rds of that
list were in at least one of the other studies.
- different versions of annotation databases were used to
create the lists, so some genes have identifiers that
changed over time and are missed in an automated com-
parison; in fact, when a current version of the Affymetrix
probeset annotations is used for the Sato study, the
intersection increases more than twofold to 16 due to sev-
eral genes having changed identifiers
These are just exemplars of the general problems of differ-
ences in gene universe (a), in gene identity (c), and in sta-
tistical criteria (b), which include not only the significance
Intersection of significant genes Figure 4
Intersection of significant genes. Improved intersection of significant genes. After our screening process, the number of 
transcripts which are up (a) and down (b) regulated in stem cells for the three studies. Notice that now most genes in each 
study also appear at least in one other study (81% Bhattacharya, 85% Sperger, 94% Sato, about 11% expected by chance), with 
a very important fraction common to all three (about 3 genes expected by chance at the intersection).BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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threshold used, but which particular test was employed to
assess it (e.g. "moderated t-statistics with fdr corrections
for multiple hypothesis"). Other general problems
affecting list intersection also include the preprocessing
steps, which have been shown to have a substantial
impact in the agreement between platforms[11,14]. So,
how should different experiments be compared? Treating
them on an equal footing goes most of the way: this
means procuring from the authors the raw data, analyzing
all studies with exactly the same statistical methods and
cutoffs, and working only on the universe of common
genes. This still does not make the studies all apples, but
it significantly approaches this goal. We further refined
this by using the notion of gene coherence; in doing so we
discovered that a number of genes are strongly incoher-
ent, behaving erratically across the studies.
The incoherent genes may behave so due to environmen-
tal interactions, differences in cell culture system or in the
differentiated states being compared. Gene expression is
the nervous system of cells, imprinted by anything in the
environment. A large number of genes are involved in
environmental interaction, leading to variability between
labs which obscure the common signal we are trying to
detect. Among the gene categories that classify the top 50
incoherent genes (see Additional file 6), i.e. those that
exhibited a significant fold change in respective studies
but that were regulated in opposite directions among the
studies, the top classifications were mainly involved with
metabolic activity, such as genes involved in the response
to oxidative stress and reactive oxygen specific genes. The
incoherent genes may also reflect differences in the condi-
tions that the labs use to grow cells. The HESC culture sys-
tem has many poorly understood variables, such as batch
to batch variation in the MEFs used to support the HESCs
and the use of serum in some culture systems. These are
both examples for which there are, as yet, no good predic-
tors for the ability to support "stemness" and can currently
only be screened by their ability to support HESC mainte-
nance based on few markers. However the list also
includes developmentally important genes, such as
MID1(Hs27695), a possible left-right determination fac-
tor [26], and FGF9(Hs111), implicated in several develop-
mental decisions. Also included were several members of
the Wnt pathway, including APC(Hs158932),
DIXDC1(Hs116796), and TLE4(Hs444213), so the inco-
herent genes may also reflect differences in the control
samples used in the studies. The Sato group uses HESCs
differentiated by withdrawal of CM, which may result in
biases in the differentiated cell types produced, while the
RT-PCR results Figure 5
RT-PCR results. Comparison between the real-time RT-PCR results and the microarray results. The blue lines are linear fits 
(without intercept) through all the 106 genes, while the magenta lines fit only the 67 genes with a fold change bigger than 0.5 
(log2-scale) in RT-PCR analysis (magenta points). (a) log2-fold change of RT-PCR vs. mean of all microarray studies (R2 = 0.5, r 
= 0.32, p < 10-16 for all genes, R2 = 0.83, r = 0.51, for the 67 top genes); (b) log2-fold change RT-PCR vs. Sato study alone, 
which had identical conditions to our study (R2 = 0.53, r = 0.41, p < 10-16 for all genes, R2 = 0.85, r = 0.59 for the 67 top genes)BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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other groups use pooled panels of RNA from a variety of
somatic tissues.
The application of microarray technology to the study of
HESC biology has the potential to provide a robust foun-
dation for the exploration of molecular networks
underlying the state of "stemness" in human embryonic
stem cells. In addition to the insight into their utility in
clinical applications provided by this exploration, eluci-
dation of these networks in HESCs shall be an important
step towards defining the molecular activity driving devel-
opment in early human embryos.
Our list of confirmed transcripts intersects three experi-
ments carried out on different cell lines, maintained in the
stemness state by different protocols, and compared
against different differentiated states. That we do get a
confirmed list under these circumstances bears witness
that there is a well-defined set of molecular circuits
involved in the state of stemness that can be studied
regardless of variations in protocol or cell line. This anal-
ysis more than octuples the list of confirmed molecular
markers of the stemness state in HESCs [27].
A balanced global assay of the molecular state of "stem-
ness" should reflect all activities of the cell including those
pathways that are necessary as well as those that are suffi-
cient for the functions of an embryonic stem cell. There-
fore, we should expect to find activities that might
include, for example, those required for the defense of
chromosomal or genetic stability as well as those required
for self-renewal in an undifferentiated state. Indeed, the
two most represented GO Biological Process in a GO/
EASE analysis of the enriched genes within our universe
are "Traversing start control point of mitotic cell cycle",
indicating a prominent role of cell cycle regulators, and
"transmembrane receptor protein serine/threonine kinase
signaling", indicating a significant role for genes involved
in sensing and responding to the developmental environ-
ment. Further, "transforming growth factor-beta receptor
activity" was the most represented GO Molecular Func-
tion classification, indicating a prominent role for TGF-
beta signaling in undifferentiated HESCs (See Additional
file 7 and Additional file 8 for the complete GO analysis).
However, because many of the genes that are important
for these and other activities may be excluded from the
universe analyzed here, we do not present the results as a
complete or unbiased picture of these activities. Instead,
this study addresses the validity of using microarray tech-
nology for building this foundation by applying consist-
ent analysis to evaluate reproducibility.
Conclusion
Our study supports concluding that the three studies are
compatible and repeatable. The method we've used dem-
onstrates that we can harness the power of several labs to
give weight to the intersection. In fact, we may conclude
that a list of regulated transcripts from a single lab
obtained under a restricted number of maintenance and
differentiation protocols should be considered with some
reserve, for we only know about coherent behavior of
genes when we have several studies to draw from. Our
results indicate that publication of the raw data is far more
valuable than publication of the analyzed data, and fur-
ther suggest that the field shall move forth only upon
agreement to set standards of backgrounds and statistical
methods.
Methods
(see Additional file 1, section Methods for a full
description)
Description of the studies
The Bhattacharya study has 6 chips. Different HESC lines
were hybridized to the red channel (Cy5) of the arrays; 5
of them were lines BG01, BG02, GE01, GE09, TE06, and
the sixth sample was a pool of GE01, GE07, and GE09.
The control sample, hybridized to the green channel was
"total human universal RNA (huURNA) isolated from a
collection of adult human tissues to represent a broad
range of expressed genes from both male and female
donors (BD Biosciences, Palo Alto, CA)". No replicates
were performed for individual lines. The Sperger study
used a similar design, hybridizing lines H1, H7, H13, H14
and two samples of H9. The control samples were "a com-
mon reference pool of mRNA". The Sato study had 6
Affymetryix HGU133A chips, 3 replicates of H1 cells (in
Matrigel/Conditioned Medium) and 3 replicates of "non-
lineage-directed differentiation" (Matrigel/non-CM).
Table 1 summarizes the architecture of chips and the
number of spot/genes involved in the three studies.
Language and packages
The statistical analysis was carried out in the R language
version 2.0 http://www.r-project.org, and packages were
from the Bioconductor project http://www.bioconduc
tor.org. Gene Ontology analysis was carried out using
EASE 2.0 software [28].
Raw data
Data from the Bhattacharya and Sato studies were
obtained directly from the authors. The Sperger data were
obtained through the Stanford Microarray Database [29].
cDNA array data were output files from GenePix 3.0.
Affymetrix raw data files were .CEL files.
We used the same image analysis criteria in all CDNA
arrays to exclude low quality spots (the criteria were differ-
ent in the published studies).BMC Genomics 2005, 6:99 http://www.biomedcentral.com/1471-2164/6/99
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Expression measures
The marray package from the Bioconductor suite was used
for cDNA arrays. Normalization was executed in two
steps, first within-print-tip-group location-dependent
intensity normalization followed by within-print-tip
group scale normalization using median absolute
deviation. Single-channel normalization of two-color
cDNA was done as proposed by [30], using quantile nor-
malization. The GCRMA algorithm was used to summa-
rize Affymetrix data as proposed in [31]. This algorithm
improves the widely used RMA [32] by including an extra
step to adjust for non-specific binding, and computing the
sequence-specific affinities between probes as described
[33].
Within-platform variability
In order to assess the quality of the data replications the
within-platform variations were analyzed. The within-
study reproducibility is overall fairly good in all the stud-
ies, even noting that Bhattacharya's and Sperger's design
contain different lines of HESC rather than true replicates
of a single line. See further details in Additional file 1.
Annotations
For both Bhattacharya and Sperger studies, annotations
were obtained from SOURCE from the Stanford microar-
ray data homepage[34]. For Affymetrix data, annotations
packages from Bioconductor were used. The IMAGE clone
IDs and the Affymetrix probes were matched using Uni-
Gene Cluster Annotation. Genes with no UniGene
number were eliminated from the study. Expression val-
ues from spots or probesets with duplicated UniGene
identifiers were averaged together.
Common genes
Annotations were obtained with the raw data from each
study. Genes without UniGene identifier were eliminated
and duplicated probes/spots were averaged together. After
this process there are 7373 genes common to all 3 studies
as shown in Supplementary Discussion Figure 8a. We fil-
tered for evidence of variation across samples, reducing
our set of interesting genes to those showed in Supple-
mentary Discussion Figure 8b. For the cDNA arrays, we
select genes where the M-values was bigger than 0.3 in at
least 4 arrays and in Affymetrix experiment we keep genes
whose expression profile had range bigger than 0.5.
Coherent genes: the integrated correlation approach
Integrated correlation analysis was introduced in [19]. For
each study s, let us define xg the expression profile for a
gene g, and   the correlation for the
pair of genes p = (g1, g2) in the study. Based on   we can
asset both overall coherence between studies and gene-
specific coherence. The integrated correlation, defined as:
 quantified the coherence between
studies. If this expression is calculated considering only
the pairs containing a gene g, then we have a measure of
the gene-specific coherence between two studies:
, where p = (g, j) When more that
two studies are involved, the average over all s and s' is
used as a Coherence Score for a gene g,
. Confidence Interval for
the correlation scores were obtained by bootstrapping.
Coherence and consistency
In [19], the coherence score defined above is called repro-
ducibility score and coherent genes (genes with high val-
ues of the score) are called "consistent". However we once
again stress that this score bears no direct logical relation-
ship to the notion of reproducibility or consistency in the
sense of consistent up- or down- regulation in both
studies. A simple counterexample makes the point: create
a fake Study 3 which is Study 2 with the values of the con-
dition and control swapped; then by the above defini-
tions, all genes are perfectly coherent for studies 2 and 3,
having coherence (reproducibility) scores equal to 1; yet
each gene which is up-regulated in study 2 is down-regu-
lated by the same amount in study 3, so all genes are
inconsistent. A relationship between the coherence scores
and consistent behaviour is predicated on the counter-
reciprocal: if a pair of genes is incoherent then both genes
cannot be consistent, and hence if a gene has a negative
coherence (reproducibility) score it is "likely" (though by
no means sure) to be inconsistent by being the "odd one
out".
Differentially expression criteria
Statistical analysis to determine which genes are differen-
tially expressed was carried out using the package Limma
from the Bioconductor project. For assessing differential
expression the moderated t-statistics was used as pro-
posed by [21] in all the 3 studies. To do so, Limma uses an
empirical Bayes method to moderate the standard errors
of the estimated log2-fold changes. This results in more
stable inference and improved power, especially for exper-
iments with small number of arrays. The p-values of the
moderated t-test were adjusted for multiple hypothesis
testing, controlling the false discovery rate (fdr) as pro-
posed [22]. We use a strict cut off criterion for selectivity
of the genes based on both the p-values and lods ratio, as
proposed in [20]. The lods (or B-statistic) is the log of the
odds that the gene is differentially expressed. For the set of
coherent genes we selected here, the cutoff of p = 0.01 and
positive lods leads to 206 (111 up, 92 down) genes while
ρp
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244 (139 up 105 down) is obtained considered only the
p-value cut-off. In Supplementary Discussion and Meth-
ods the reader can find how the number of selected genes
depends on the criteria for different set of coherent genes.
Real-time RT-PCR verification of gene expression level in 
HESCs
Relative expression levels of the 106 (95%) of 111 genes
in the intersection were analyzed in H1 HESCs main-
tained in CM or differentiated by withdrawal of CM for 30
days by real-time RT-PCR. Raw data were normalized to
Ubiquitin-C expression and relative expression levels
were determined using PCR efficiency-adjusted ratios
[35].
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